纤维蛋白调节纳米凝胶治疗弥散性血管内凝血
本研究开发了载组织型纤溶酶原激活剂的纤维蛋白特异性核壳纳米凝胶(tPA-FSNs),旨在靶向溶解微血栓并改善DIC出血。在DIC啮齿动物模型中,tPA-FSNs减少多器官微血栓、恢复血小板计数并改善出血结局;与人DIC患者血浆结合时,可恢复血流下血凝块结构和生长。
要点
- tPA-FSNs在DIC动物模型中减少微血栓并改善出血。
- tPA-FSNs可恢复DIC患者血浆在血流下的凝块结构。
- 纤维蛋白靶向纳米凝胶可能同时解决DIC血栓与出血矛盾。
核心结论
- 载tPA的纤维蛋白靶向纳米凝胶可改善DIC模型中的微血栓和出血结局。
研究设计与样本
- 研究开发了载tPA的纤维蛋白特异性核壳纳米凝胶(tPA-FSNs),并在DIC啮齿动物模型和人DIC患者血浆中评估。
主要发现
- 在DIC啮齿动物模型中,tPA-FSNs减少多器官微血栓表现、恢复血小板计数并改善出血结局。
- 与人DIC患者血浆结合时,tPA-FSNs在流动条件下恢复血凝块结构和血凝块生长。
临床怎么用
- 该纳米凝胶策略可能为DIC中微血栓和出血的矛盾管理提供靶向治疗方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Disseminated intravascular coagulation (DIC) is a pathological coagulopathy associated with infection that increases mortality. In DIC, excessive thrombin generation causes symptoms from formation of microthrombi to multiorgan failure; bleeding risks can also be a concern because of clotting factor consumption. Different clinical events lead to DIC, including sepsis, trauma, and shock. Treatments for thrombotic episodes or bleeding presentation in DIC oppose each other, thus creating therapeutic dilemmas in management. The objective of this study was to develop fibrin-specific core-shell nanogels (FSNs) loaded with tissue-type plasminogen activator (tPA) to treat the microcirculatory complications of DIC, which would facilitate targeted clot dissolution to manage microthrombi and the potential consumptive coagulopathy that causes bleeding. FSNs enhance formation of actively polymerizing clots by crosslinking fibrin fibers, but they can also target preexisting microthrombi and, when loaded with tPA, facilitate targeted delivery to lyse the microthrombi. We hypothesized that this dual action would simultaneously address bleeding and microthrombi with DIC to improve outcomes. In vivo, tPA-FSNs decreased the presentation of multiorgan microthrombi, recovered platelet counts, and improved bleeding outcomes in a DIC rodent model. When incorporated with human DIC patient plasma, tPA-FSNs restored clot structure and clot growth under flow. Together, these data demonstrate that a fibrinolytic agent loaded into fibrin-targeting nanogels could improve DIC outcomes.
引用
- Mihalko EP, Sandry M, Mininni N, et al. Fibrin-modulating nanogels for treatment of disseminated intravascular coagulation. Blood Adv. 2021. PMID: 33560377. doi:10.1182/bloodadvances.2020003046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。